Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: "We expect PDS will fund its operations through licensing revenue."

BUT: Where's APple?

report depending on date of tpl settlement oct.6th 2011? still to come?

Share
New Message
Please login to post a reply